# Processa Pharmaceuticals, Inc.: Form 8-K/A, filed Oct 17, 2017

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K/A
- Filed: 2017-10-17
- Accepted by EDGAR: Oct 17, 2017, 16:26 ET
- Period: 2017-10-04
- Accession: 0001393905-17-000317
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000139390517000317/pcsa_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000139390517000317/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000139390517000317/pcsa_8ka.htm

Filed Oct 17, 2017.
Source: SEC EDGAR, the filing index for accession 0001393905-17-000317. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
